Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00693706 · ClinicalTrials.gov registry record · Phase 1

Safety and Immune Response Study of GSK Biologicals' Influenza Virus Vaccine 1388442A Compared With Fluarix

A Phase 1 study of Influenza, sponsored by GlaxoSmithKline.

Completed
Registry status
Phase 1
Development phase
200
Enrollment target
2
Study locations

NCT00693706 is a Phase 1 study of Influenza that has completed, run by GlaxoSmithKline. The registered enrollment target is 200 participants, below the 36,803-participant average among 156 other Influenza trials with a reported enrollment target (99% lower). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00693706, a Phase 1 study of Influenza, has completed, sponsored by GlaxoSmithKline.

COMPLETED
Registry status
Phase 1
Development phase
200 participants
Enrollment target
2
Study locations

Study Summary

The purpose of the study is to compare the safety of \& immune response to a single dose of GSK Biologicals' cell-culture based influenza vaccine 138842A with that of a US licensed, egg-based trivalent influenza vaccine \[Fluarix\] in healthy adults.

Conditions Studied

Influenza

Interventions

  • BIOLOGICAL Trivalent influenza vaccine GSK 138842A
  • BIOLOGICAL Fluarix

Study Locations (2)

Florida

  • GSK Investigational Site - Miami

Kansas

  • GSK Investigational Site - Lenexa

Trial Details

FieldValue
Enrollment Target 200 participants
Start Date 2008-06-02
Est. Completion 2009-03-26
Phase Phase 1

Sponsor

GlaxoSmithKline

1,345 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00693706

The ClinicalTrials.gov registry entry for NCT00693706 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 36,803-participant average among 156 other Influenza trials with a reported enrollment target (99% lower). The listed sponsor is GlaxoSmithKline, which has 1,345 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Influenza appearing as the primary indexed condition, and to 2 interventions - of which Trivalent influenza vaccine GSK 138842A is the first listed.

NCT00693706 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Florida, Kansas.

Frequently Asked Questions

What is clinical trial NCT00693706 about?

NCT00693706 is a clinical study titled "Safety and Immune Response Study of GSK Biologicals' Influenza Virus Vaccine 1388442A Compared With Fluarix". The purpose of the study is to compare the safety of \& immune response to a single dose of GSK Biologicals' cell-culture based influenza vaccine 138842A with that of a US licensed, egg-based trivalent influenza vaccine \[Fluarix\] in healthy adults.

What is the current status of trial NCT00693706?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 200 participants. The study started on 2008-06-02. Estimated completion is 2009-03-26.

What conditions does trial NCT00693706 study?

This clinical trial studies the following conditions: Influenza.

What interventions are being tested in trial NCT00693706?

The interventions under investigation include: Trivalent influenza vaccine GSK 138842A (BIOLOGICAL), Fluarix (BIOLOGICAL).

Who is sponsoring clinical trial NCT00693706?

This trial is sponsored by GlaxoSmithKline, which has 1,345 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00693706 being conducted?

This trial has 2 study locations across Florida, Kansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Influenza

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Influenza

All registered trials for this condition

Florida

All trials with a study site in Florida

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.